Immune Mediated Vaccines

Patients with safe interceded incendiary ailments (IMID, for example, RA, IBD or psoriasis, are at augmented danger of contamination, in part in light of the malady itself, however for the most part in light of treatment with immunomodulatory or immunosuppressive medications. Regardless of their raised hazard for immunization preventable ailment, inoculation scope in IMID patients is shockingly low.

  • Central nervous system-targeted & Tissue-specific autoimmunity
  • Innate immunity and diabetes vaccines
  • Vaccination strategy in patients with IMID
  • Vaccine safety: impact on disease activity in IMID patients
  • Vaccines for autoimmune skin disorders & neuropathies
  • Vaccines for immunodeficiency diseases

Related Conference of Immune Mediated Vaccines

March 18-19, 2019

33rdAnnual Vaccines & Vaccination Congress

New York, USA
March 18-19, 2019

35th World Vaccines & Immunization Congress

Novotel Brisbane, Australia
March 21-22, 2019

32nd International Conference on Vaccines and Immunization

Hotel Holiday Inn, Aurelia Rome, Italy
August 12-13, 2019

34th World Congress on Vaccines and Immunization

Auckland, New Zealand

Immune Mediated Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in